🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsPatient preference: weekly injection vs potential monthly depot — need advice Page 4

Patient preference: weekly injection vs potential monthly depot — need advice

BrianDallas92 Sat, Sep 20, 2025 at 3:44 AM 32 replies 1,267 viewsPage 4 of 7
mia_MS2
New Member
8
23
Mar 2026
Ann Arbor, MI
Sep 20, 2025 at 9:24 AM#16

Just wanted to say — for anyone reading this Patient preference thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

31 14ricardo_MIA, BrianDallas92, labquiet_amy and 28 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Sep 20, 2025 at 9:41 AM#17

BrianDallas92's experience with Patient preference weekly resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 44 lbs in 9 months.

One thing I would add that BrianDallas92 did not mention: the relationship with food fundamentally changed.

7 4ZaraB_AL, JakeSmashed95, NauseaFreeNow and 4 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Mar 2026
Virginia
Online
Sep 20, 2025 at 9:58 AM#18

Saving this for reference. Quality thread.

Last edited: Sep 20, 2025 at 12:58 PM
15 1MeganSA_TX, LarryQC_SD, wanda_boise and 12 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Sep 20, 2025 at 10:15 AM#19

As a healthcare provider, I want to add some clinical context to this discussion on Patient preference weekly injection vs.

Building on what BrianDallas92 said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
28 13B12Beth, RickReta_CO, PharmHunterJen and 25 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Sep 20, 2025 at 10:32 AM#20

Subscribing to this thread. Patient preference weekly is exactly what I've been researching. 🙏

Last edited: Sep 20, 2025 at 1:32 PM
48 7jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 45 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register